Monday, March 16, 2020

34th World Congress on Heart Diseases

Crowd Reviews Partnered with Pulsus to Announce: Unleash the Enigma in Cardiology/ Heart Diseases through Heart Congress 2020

Pulsus Group hosts the 34th World Congress on Heart Diseases (Heart Congress 2020) that discusses the new paradigm approach to probe every single element in Cardiology/ Heart Disease. Heart Congress 2020 focuses on many interactive scientific sessions on different types of Blood disorders and Cancers as well as various diagnostic and therapeutic advancements in this field. It also provides an opportunity to showcase your ingenuity to the world. Heart Congress 2020 will be organized around the theme “Renovation to Modulate the pulse that beats for your life” on July 27- 28, 2020 at Madrid, Spain.

The major focus on the Conference includes about new mechanisms for targeting specific Proteins in Blood Stream, Latest uses of Heart Cells in Medicine, Advances in Hematology/ Cardiology, Emerging trends in Stem Cell research, Advancements in Diagnostic & Therapeutic areas of Cardiology, Future directions in Pediatric Cardiology/ Heart Diseases and many more.

The attendees of the Congress will enjoy special events and lectures featuring expertise in the field. It is a perfect platform for Cardiologists, Cardiac Surgeons, immunologists, pathologists, research scholars, University Professors, industrial professionals and student delegates from biomedical and healthcare sectors to explore every single element in Cardiology/ Heart Diseases. Heart Congress 2020 will also provide an excellent opportunity for the budding scientists and young researchers through its special initiatives like Young Researcher Forum, Poster Presentation, B2B and Scientific Meetings.

All the papers to be presented in Heart Congress 2020 will be published in Clinical Cardiology Journal, Current Research: Cardiology, Journal of Cardiology and Clinical Therapeutics.

Conference Highlights:

· Only 45% of the global blood supply is collected in developing countries, which are home to more than 80% of the world’s population.
· 41 out of 148 countries (28%) that provided data on screening for transfusion-transmissible infections including HIV, hepatitis B and C, and syphilis were not able to screen all donated blood for one or more of these infections.
·Heart Failure is often considered a disease of affluence, but about 70% of Heart Diseases deaths occur in low- and middle-income countries.
· A 2012 study in The Lancet Cardiology predicted that from 2008-2030, Heart Diseases incidence will rise 75 percent globally and will double in the least developed countries.
· Sickle cell disease (SCD) affects millions of people throughout the world and is particularly common among those whose ancestors came from sub-Saharan Africa; Spanish-speaking regions in the Western Hemisphere (South America, the Caribbean, and Central America); Saudi Arabia; India; and Mediterranean countries such as Turkey, Greece, and Italy.
· Hemophilia A affects 1 in 5,000 male births. About 400 babies are born with hemophilia A each year.

If you are interested to know more about the Congress,
Contact: Emma Parker
Tel.: +44-203-769-1778
Email: cardionheart@gmail.com, heartcongress@meetingsnexpo.com